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Abstract
   This study is to review and retrieve data on adult hepa-
toblastoma (HB) from English literatures in order to gain a 
better understanding of this disease. We performed Medline, 
PubMed (from January 1966 to February 2008), and library 
searches (National Science and Technology Library, Beijing, 
China, and Wenzhou Medical College Library, from January 
1980 to February 2008) using the key words hepatoblastoma 
in  adult,  hepatic  tumor,  hepatoblastoma  and  adult.  Previ-
ously reported HB cases were collected and published re-
views were also examined. Fifteen cases that met the search 
criteria were selected. Review of the cases revealed a slight 
female preponderance. The patients’ age ranged from 17 to 
82, with median age of 70 for male and 27 for female. The 
survival time ranged from two weeks to 38 months, and the 
median survival time was 6 months. In the articles reviewed, 
HB presented with non-specific initial symptoms, and the 
diagnosis was not identified until the tumor biopsy after op-
eration or autopsy. Completely surgical resection is still the 
major treatment for patients with HB and is considered as 
the only chance of a better prognosis. Due to the rareness 
of HB in adults, the choice of treatment should be radical 
resection if possible, and combined with chemotherapy as 
adopted in children. HB in the adult is extremely rare and the 
pre-operative diagnosis is often overlooked. The prognosis is 
so poor that the awareness of the condition in the differential 
diagnosis in liver tumors could be beneficial.
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Introduction
     Hepatoblastoma (HB) is a rare malignant tumor of the 
liver, which comprises over two-thirds of the malignant tu-
mors of the liver in children [1], with most occurring before 
the age of 5 [2]. It accounts about 1-4% of all primary ma-
lignancy in children [3]. Most of these tumors arise in the 
embryo, hence it seems to be unusual that HB occur in adults 
and are an exceptional cause of primary malignant liver tu-
mor in adult patients [4]. Although the existence of HB in 
adult patients has been refuted by some authors, approxi-
mately 40 adult cases of HB have been reported [5-7], with 
non-specific initial symptoms and difficulty in discerning ir-
regularities in the laboratory studies of the patients. Conse-
quently, the diagnosis is often overlooked, and patients may 
present at the late stages of the disease at risk of increased 
mortality.
Literature retrieval
  The We performed Medline, PubMed (from January 
1966 to February 2008), and Library searches (National Sci-
ence and Technology Library, Beijing, China, and Wenzhou 
Medical College Library, from January 1980 to February 
2008) using the following keywords, hepatoblastoma in the 
adult, hepatic tumor, hepatoblastoma and adult. In addition, 
references of the articles were obtained and previous reviews 
were also examined. The literature searches were limited to 
the English language literature. All patients listed in Table 
1 are over 17 years old, the cases associated with other pa-
thologies,  such  as  hepatocellular  carcinoma  (HCC),  were 
excluded.
  We retrieved 15 cases based on the search criteria. 
Table 1 lists 14 articles that met the inclusion criteria [3-5, 
7-17]. There were 7 cases in case reports [3, 5, 7-9, 14, 17]; 
other 6 cases were in the review literatures [4, 10-12, 15, 16] 
and in one case series [13].
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Discussion
     HB is the most common primary malignant liver neo-
plasm in children [1, 18]. Approximately 90% of the cases 
occur in patients under 5 years of age and two thirds of the 
cases occur in the first 2 years of life [2, 19]. Boys are affect-
ed twice than girls [20]. HB in adolescent and young adults 
is extremely rare and the prognosis is much worse than the 
HB in childhood, because they are usually diagnosed late [4, 
16]. Review of the studies on HB in the adults, revealed a 
slight female preponderance (9 female versus 6 male). The 
age of the patients reported in the literature ranged from 17 
to 82, with a median age of 70 years for male and 27 years 
for female.
       The etiology of HB has been elusive. Present investiga-
tions of the cytogenetic and molecular genetic abnormalities 
in HB revealed involvement of chromosomal loci on 1q, 2 
(or 2q), 4q, 8 (or 8q), and 20 [21]. Loss of heterozygosity 
imprinting at locus 11p 15.5 also suggests a common genetic 
basis for HB [21]. The detection of nuclear β-catenin accu-
mulation implies an oncogene alteration of the wnt/β-catenin 
pathway. Furthermore, nuclear p53 accumulation indicates 
that p53 mutation is also involved in the molecular patho-
genesis  of  the  malignancy  [22].  Based  on  embryological 
theory, it is believed that HB arises from a hepatic blastema. 
However, this hypothesis seems to be inapplicable to adult 
HB. Four patients [5, 8, 12, 13] in the literature were more 
than 70 years old. The persistence of primitive hepatic blas-
Table 1.  Summary of hepatoblastoma in adults
Ref. No.
Sex/Age 
(yr)
Location Size (cm) Histology Procedure
Survival 
(Mon)
POD MET
8 M/78 L 19×6×1 Mixed SR 1 Ab Y
9 F/19 R 19 Mixed  SR NR NR NR
10 F/27 R 25 Mixed  SR 18 ALA N
11 M/22 L 6.5×6×6 Embryonic
SR+TAE
+CT
9 NR Y
12 M/82 L+R Child head size Mixed  CT+TAE 6 HCC N
13 M/73 NR 18×18×10 Mixed  NR NR NR NR
13 F/35 NR NR Epithelial NR NR NR NR
14 F/22 Medial part 14×13×13 Epithelial SR 38 NR N
4 F/51 L 11×7 Mixed SR 2 HCC NR
7 M/67 R 8×6 Mixed  SR 0.5 NR N
5 F/78 R 23 Mixed SR  2 NR N
15 F/52 L+R 22×16×15, 2.5 Mixed  SR+RFA  6 HCC NR
16 F/19 R 14×12×10 Mixed SR+CT 6 NR NR
3 F/17 R 11.9×10.4 Epithelial CT NR NR NR
17 M/34 R 17×11×9 Mixed  SR 3 NR N
M: Male; F: Female; L: Left lobe; R: Right lobe; Y: Yes; N: No; NR: No report; SR: Surgical resection; CT: Chemotherapy; 
TAE: Transcatheter arterial embolization; RFA: Radio-frequency ablation; POD: Pre-operative diagnosis; Ab: Abdominal 
aortic aneurysm; ALA: Amoebic liver abscess; HCC: hepatocellular carcinoma; MET: Metastasis.
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tema for such a long period seems unlikely. Furthermore, the 
presence of cirrhosis in liver with HB is not seen in children. 
However, cirrhosis of the liver has been seen in association 
with adult HB in 30% of cases [5, 6]. This would imply that 
these tumors may have a different pathogenetic pathway in 
adults compared to children.
       The histological classification of HB was originally 
proposed by Ishak and Glunz [23], and has now gained wide 
acceptance. Among the cases summarized in Table 1, the 
mixed type (11/15) was predominated compared to the epi-
thelial type (4/15). The tumors can be unifocal or multifo-
cal, most occur as single mass (12/15) either in right lobe 
(7/12) of liver or in left lobe (3/12), or both of the two lobes 
(2/12). There is only one case reported as multifocal (1/15). 
The sizes of the masses ranged from 2.5 to 25 cm. The usual 
presentation is failure to thrive, loss of weight and a rapidly 
enlarging upper abdominal mass. Some presented with pain, 
fever and vomiting.
        The initial diagnosis of HB is mainly based on imag-
ing. Proper diagnosis, staging and treatment of HB require 
accurate imaging studies. Ultrasound (US) is a non-invasive 
modality that is particularly useful in the evaluation of in-
fants. HB is seen as a hyperechoic, solid, intrahepatic mass 
on US [24]. Other standard investigations include computed 
tomography (CT), magnetic resonance imaging (MRI), se-
rum AFP and β-HCG. However, the final diagnosis relies 
on tumor biopsy. While in the adult, the morbidity of HB is 
extremely rare and the initial symptoms are non-specific so 
that the diagnosis is often overlooked. Furthermore, it is also 
difficult to make a pathologic diagnosis of adult HB, since 
there are several similar types of tumor such as hepatic tera-
toma, carcinosarcoma, malignant mesenchymal tumor and 
HCC with sarcomatous changes and hepatoblastomatous le-
sions [12]. In almost all of the cases summarized in Table 1, 
the diagnosis of HB was not made until the tumor biopsy or 
autopsy. The pre-operative diagnosis (POD) of three cases 
were HCC [4, 12, 15] and two cases were abdominal aortic 
aneurysm and hepatic amoebic abscess [8, 10] respectively. 
       The complete surgical resection is the cornerstone of 
treatment for patients with HB and is the only chance of an 
optimal clinical outcome. Despite this, the improvements in 
survival that have occurred over the last three decades have 
been a function of standardized chemotherapy regimens that 
reduce tumor size and enable complete tumor excision, even 
permitting cure in the presence of initially unresectable or 
metastatic disease [25]. Chemotherapy has been proven ef-
fective in both an adjuvant and neoadjuvant treatment and 
can shrink tumors. It makes them less prone to bleed and 
delineates the tumor from the surrounding normal parenchy-
ma and vascular structures so as to facilitate the resections. 
HB is sensitive to such chemotherapy drugs as doxorubicin, 
cisplatin, vincristine, 5-FU and cyclophosphamide [26]. Fur-
thermore, liver transplantation has recently been associated 
with significant success in the treatment of children with un-
resectable hepatic tumors. Post-transplant survival rates as 
high as 80% have been reported for children with HB [27]. 
The current 5-year survival rate in children is 75% compared 
with a 5-year survival rate of 35% almost 30 years ago [18, 
28]. Because lack of experience of HB in adult patients, it is 
reasonable to select radical resection and chemotherapy for 
HB in adults. Of the 15 cases, 9 cases were treated with sur-
gical resection, 2 with surgery and postoperative chemother-
apy, and one with transcatheter arterial embolization (TAE).
        Despite the progress of therapy, 20%-30% of HB pa-
tients have a fatal outcome. Prognostic factors are needed for 
better therapy planning in these patients [29]. The prognosis 
is poor in multiple lobes involvement, embryonic type, de-
creased P27 gene expression, multifocal dissemination, AFP 
level lower than 100 or higher than 100000 ng/ml [3, 30], 
and the RASSF1A methylation [29]. In our review of the 
literature, we found there were 5 cases (33.3%) with AFP 
increasing [4, 5, 11, 14, 17]. The survival time ranged from 
two weeks to 38 months, and the median survival time was 
6 months, this was much worse compared with childhood 
patients.
          With the low incidence and non-specific initial symp-
toms, HB in the adult presents a diagnostic challenge, de-
manding a high index of suspicion and a thorough evalua-
tion. Because the prognosis could be improved with early 
detection, diagnosis and treatment, it is important for clini-
cians to be aware of the condition in order to benefit the pa-
tients.
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